MD Anderson Cancer Center
MD Anderson is globally renowned for its cutting-edge research, exceptional patient care, innovative prevention programs and commitment to training the next generation of oncology experts. In Fiscal Year 2021, MD Anderson clinicians treated more than 400 types of cancer and cared for 174,126 patients. 9,684 of our patients enrolled in 1,600 clinical trials led by our experts. We contributed to 60% of new cancer drugs approved by the Food and Drug Administration in 2021 and had 195 patents awarded. MD Anderson was again ranked No. 1 in cancer care by U.S. News & World Report in 2021.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No